v3.25.2
Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2023   17,564,182      
Balance at beginning of period at Dec. 31, 2023 $ 254,935 $ 17,564 $ 168,614 $ 124,400 $ (55,643)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income 2,459       2,459
Dividends on common shares (3,951)     (3,951)  
Issuance of restricted stock, net of forfeitures (in shares)   (594)      
Issuance of restricted stock, net of forfeitures 0        
Tax withholding related to vesting of restricted stock (in shares)   (4,977)      
Tax withholding related to vesting of restricted stock (66) $ (5) (61)    
Repurchase and retirement of shares (in shares)   (20,000)      
Repurchase and retirement of shares (239) $ (20) (219)    
Stock-based compensation expense 798   798    
Net income 10,807     10,807  
Balance at end of period (in shares) at Jun. 30, 2024   17,538,611      
Balance at end of period at Jun. 30, 2024 264,743 $ 17,539 169,132 131,256 (53,184)
Balance at beginning of period (in shares) at Mar. 31, 2024   17,558,611      
Balance at beginning of period at Mar. 31, 2024 259,914 $ 17,559 168,951 127,758 (54,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income 1,170       1,170
Dividends on common shares (1,976)     (1,976)  
Repurchase and retirement of shares (in shares)   (20,000)      
Repurchase and retirement of shares (239) $ (20) (219)    
Stock-based compensation expense 400   400    
Net income 5,474     5,474  
Balance at end of period (in shares) at Jun. 30, 2024   17,538,611      
Balance at end of period at Jun. 30, 2024 $ 264,743 $ 17,539 169,132 131,256 (53,184)
Balance at beginning of period (in shares) at Dec. 31, 2024 17,519,884 17,519,884      
Balance at beginning of period at Dec. 31, 2024 $ 278,675 $ 17,520 168,353 140,369 (47,567)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income 5,909       5,909
Dividends on common shares (4,022)     (4,022)  
Issuance of restricted stock, net of forfeitures (in shares)   1,890      
Issuance of restricted stock, net of forfeitures 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock (in shares)   (4,748)      
Tax withholding related to vesting of restricted stock (77) $ (5) (72)    
Repurchase and retirement of shares (in shares)   (100,324)      
Repurchase and retirement of shares (1,589) $ (100) (1,489)    
Stock-based compensation expense 370   370    
Net income $ 14,591     14,591  
Balance at end of period (in shares) at Jun. 30, 2025 17,416,702 17,416,702      
Balance at end of period at Jun. 30, 2025 $ 293,857 $ 17,417 167,160 150,938 (41,658)
Balance at beginning of period (in shares) at Mar. 31, 2025   17,481,709      
Balance at beginning of period at Mar. 31, 2025 286,925 $ 17,482 167,876 144,967 (43,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income 1,742       1,742
Dividends on common shares (2,007)     (2,007)  
Issuance of restricted stock, net of forfeitures (in shares)   (2,990)      
Issuance of restricted stock, net of forfeitures 0 $ (3) 3    
Repurchase and retirement of shares (in shares)   (62,017)      
Repurchase and retirement of shares (959) $ (62) (897)    
Stock-based compensation expense 178   178    
Net income $ 7,978     7,978  
Balance at end of period (in shares) at Jun. 30, 2025 17,416,702 17,416,702      
Balance at end of period at Jun. 30, 2025 $ 293,857 $ 17,417 $ 167,160 $ 150,938 $ (41,658)